Sonix Health vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Sonix Health

by Ontact Health Co.

EchoNext

by Pathway Labs

AI Verdict

Sonix Health and EchoNext are adjacent tools in cardiology AI. Sonix Health focuses on automating echocardiography analysis for enhanced diagnostic precision, while EchoNext analyzes standard ECGs to detect hidden structural heart disease. Therefore, Sonix Health would be chosen for detailed ultrasound analysis, and EchoNext for initial screening and risk identification via ECG.

Choose Sonix Health if…

Choose Sonix Health if your cardiology practice or department needs to significantly enhance the efficiency and precision of echocardiography analysis. This tool is ideal for automating measurements, generating reports, and improving diagnostic accuracy for cardiac ultrasound images, ultimately reducing examination time and staff workload.

View Sonix Health →

Choose EchoNext if…

Choose EchoNext if your healthcare setting aims to leverage standard ECGs for early detection and screening of hidden structural heart diseases, such as heart failure, valve disease, and pulmonary hypertension. This tool is particularly well-suited for identifying high-risk patients who may require further evaluation with an echocardiogram, thereby enabling earlier intervention for conditions that might otherwise go undiagnosed.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Sonix Health	EchoNext
Pricing	Contact vendor for pricing.	Starts at $600/month
Deployment	Software only, installed directly on customer PC hardware; also offers cloud or on-premise options.	Available through the OpenEvidence clinical decision support platform.
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Sonix Health

Sonix Health emphasizes 'Simplicity in Experience' and 'One-touch analysis and diagnosis,' aiming to streamline workflows and reduce staff workload. User testimonials highlight quicker results, easier hospital visits, and a streamlined ultrasound examination process. EchoNext's deployment through the OpenEvidence platform suggests a focus on integration, but direct claims or testimonials about its ease of use for clinicians are less prominent than Sonix Health's.

Clinical Value

EchoNext

EchoNext has demonstrated superior diagnostic accuracy compared to cardiologists in detecting structural heart disease from ECGs, with an accuracy of 77% compared to cardiologists' 64%. It was trained on over 700,000 ECG-echocardiogram pairs and has been validated in studies across more than 20 hospitals and 500,000 patients. Sonix Health provides automated echocardiography analysis with high accuracy for various measurements and view classification, and has published clinical evidence, but direct comparisons to human expert performance in diagnostic accuracy are not as explicitly stated or as compelling as for EchoNext.

Pricing & Value

EchoNext

EchoNext offers transparent tiered pricing starting at $600/month, with details on different plans, implementation fees, and annual discounts. This transparency allows potential customers to better understand the cost. Sonix Health only states 'contact vendor for pricing,' which offers no immediate insight into its cost structure.

Enterprise Readiness

Tie

Both tools are FDA-cleared and HIPAA compliant, essential for enterprise deployment. Sonix Health offers flexible deployment options (PC, cloud, or on-premise) and vendor-independent technology, indicating strong adaptability to various IT infrastructures. EchoNext is available through the OpenEvidence clinical decision support platform, which is used by over half of US clinicians, suggesting a broad reach and established integration pathway within healthcare systems.

Innovation

EchoNext

EchoNext is highlighted as the 'world's first FDA-approved AI detection tool that reads standard 12-lead electrocardiograms (ECGs) to flag high risk structural heart diseases'. It addresses a significant gap in early detection of heart disease using a widely available and inexpensive test. Sonix Health offers innovative automated echocardiography analysis, including auto strain without EKG and an image quality meter, but EchoNext's ability to detect hidden structural heart disease from routine ECGs represents a more paradigm-shifting innovation in early screening.

Support & Docs

Sonix Health

Sonix Health (referring to Sonix.ai, a related entity with similar support structure) provides comprehensive support options including email, live chat, and phone support, with a stated average response time of less than 4 hours and a 98% satisfaction rate. They also offer a 24/7 help center, advanced training, and dedicated account managers for enterprise customers. EchoNext's documentation mentions its availability through the OpenEvidence platform, but specific details about its direct customer support channels or extensive documentation are not as readily available.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Sonix Health	EchoNext
Name	Sonix Health	EchoNext
Company	Ontact Health Co.	Pathway Labs
Description	FDA-cleared AI-powered echocardiography analysis solution that automates the measurement and reporting of cardiac ultrasound images, enhancing efficiency and diagnostic precision for physicians.	FDA-cleared AI tool from Pathway Labs that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.
Key Features	AI-Powered Fully-Automated Echocardiography Analysis, View Recognition (classification of 37 FDA-approved views with 96.25% accuracy), Auto Measure (automated quantification of B-mode, M-mode, Doppler parameters), Auto Strain (automated LV, LA, and RV Strain analysis without EKG), Image Quality Meter (AI-powered image selection for precision diagnostics), DICOM Compliant, Automated Report Generation, Vendor-independent technology	AI-powered ECG analysis, Detection of hidden structural heart disease, Identifies heart failure risk, Screens for valve disease, Detects pulmonary hypertension indicators, Utilizes standard 12-lead ECGs, FDA-cleared technology, Non-invasive diagnostic support
Categories	Cardiology AI	Cardiology AI, Clinical Decision Support & Reference, Lab & Diagnostics
Specialties	Cardiology, Critical Care, Radiology	Cardiology, Family Medicine, Hospital Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Sonix Health and EchoNext.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate with existing EHR systems and clinical workflows?

Sonix Health is designed for seamless, automated echocardiography analysis, from cardiac imaging to report generation, and is vendor-independent, allowing for flexible integration with various systems and devices. EchoNext integrates with the OpenEvidence clinical decision support platform, which is used by many physicians, aiming to embed its screening output directly into existing clinical workflows rather than requiring a separate system.

What is the accuracy and sensitivity of each tool in detecting cardiac conditions?

Sonix Health boasts high accuracy in its echocardiography analysis, with 96.25% accuracy in view recognition and 97.5% accuracy compared to manual measurements for 81 parameters. EchoNext, an AI-powered ECG model, demonstrated an AUROC of 85.2% in detecting structural heart disease (SHD) in internal tests and 78-80% in external validation, outperforming cardiologists who achieved 64% accuracy in a study.

What is the learning curve for physicians and staff, and what training and support are provided?

Sonix Health aims for simplicity in experience, with automated analysis making it easier for even less skilled medical staff to view results and accelerating learning during training. While specific learning curve details for EchoNext are not provided, its integration with the widely used OpenEvidence platform suggests an effort to streamline adoption within familiar physician tools. Sonix (the company behind Sonix Health) offers a comprehensive training program with self-guided videos, hands-on procedure training, and on-site support for the first two procedure days to help staff move through the learning curve effectively.

What clinical context or specific patient populations are these tools best suited for?

Sonix Health is an echocardiography analysis solution, making it suitable for situations requiring detailed cardiac ultrasound image analysis and reporting, particularly in cardiology, critical care, and radiology. EchoNext is designed as a screening tool that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, making it valuable for broad access from major hospitals to community practices to identify patients who should be referred for an echocardiogram.

Are there audit-trail features available to track usage and data access?

Sonix Health (through Sonix) offers comprehensive audit trails that track every access, view, edit, and share of transcripts containing PHI, which helps meet HIPAA audit requirements with complete activity records. For EchoNext, the information provided does not explicitly detail its audit-trail features, but generally, continuous monitoring and maintaining audit logs are crucial for integrated health apps.

What are the considerations for rolling out these tools across multiple sites or a large health system?

Sonix Health is designed with vendor-independent technology and multi-vendor data training, suggesting seamless compatibility and stable operation across diverse environments and existing equipment, which would facilitate multi-site rollouts. EchoNext's partnership with OpenEvidence aims to get the tool into real workflows across health systems at a national scale, suggesting a focus on broad accessibility and integration into existing clinical decision support platforms for widespread adoption.